Rencofilstat, a pan-cyclophilin inhibitor, exerts diverse metabolic and transcriptional anti-tumor activities in a murine NASH-HCC model

Daren Ure(NAEJA-RGM Pharmaceuticals (Canada)), Philippe Gallay(Scripps Research Institute), Patrick Mayo(Scripps Research Institute), Lacey Haddon, Robert E. Foster(Cincinnati Eye Institute), Winston T Stauffer(San Diego State University), Joseph Kuo(Scripps Research Institute)
Journal of Hepatology
July 1, 2022
Cited by 0


Related Papers